[HTML][HTML] Update on global epidemiology of viral hepatitis and preventive strategies

M Jefferies, B Rauff, H Rashid, T Lam… - World journal of clinical …, 2018 - ncbi.nlm.nih.gov
Viral hepatitis is one of the major public health concerns around the world but until recently it
has drawn little attention or funding from global health policymakers. Every year 1.4 million …

Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework

E Day, M Hellard, C Treloar, J Bruneau… - Liver …, 2019 - Wiley Online Library
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …

Prevalence of hepatitis C virus infection in US states and the District of Columbia, 2013 to 2016

ES Rosenberg, EM Rosenthal, EW Hall… - JAMA network …, 2018 - jamanetwork.com
Importance Infection with hepatitis C virus (HCV) is a major cause of morbidity and mortality
in the United States, and incidence has increased rapidly in recent years, likely owing to …

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)

LT Fadnes, CF Aas, JH Vold, RA Leiva… - PLoS …, 2021 - journals.plos.org
Background The standard pathways of testing and treatment for hepatitis C virus (HCV)
infection in tertiary healthcare are not easily accessed by people who inject drugs (PWID) …

[PDF][PDF] Hepatitis C virus prevalence in 50 US states and DC by sex, birth cohort, and race: 2013‐2016

H Bradley, EW Hall, EM Rosenthal… - Hepatology …, 2020 - Wiley Online Library
Hepatitis C virus (HCV) infection is a leading cause of liver‐related morbidity and mortality,
and more than 2 million adults in the United States are estimated to be currently infected …

[HTML][HTML] The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the …

S Popping, D Bade, C Boucher, M van der Valk… - Journal of virus …, 2019 - Elsevier
Hepatitis B virus (HBV) and hepatitis C virus (HCV) affect more than 320 million people
worldwide, which is more than HIV, tuberculosis (TB) and malaria combined. Elimination of …

Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries

R Bielen, SR Stumo, R Halford, K Werling, T Reic… - Harm reduction …, 2018 - Springer
Background Current estimates suggest that 15% of all prisoners worldwide are chronically
infected with the hepatitis C virus (HCV), and this number is even higher in regions with high …

A global systematic review of hepatitis C elimination efforts through micro-elimination

JV Lazarus, CA Picchio, CJ Byrne… - Seminars in liver …, 2022 - thieme-connect.com
Microelimination targets specific subpopulations and/or geographic settings for hepatitis C
virus (HCV) elimination. This review reports on global HCV microelimination literature …

Integrated, co-located, telemedicine-based treatment approaches for hepatitis C virus management in opioid use disorder patients on methadone

AH Talal, P Andrews, A Mcleod, Y Chen… - Clinical Infectious …, 2019 - academic.oup.com
Background Despite high hepatitis C virus (HCV) prevalence, opioid use disorder (OUD)
patients on methadone rarely engage in HCV treatment. We investigated the effectiveness of …

Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden

K Lindqvist, Z Thorin, M Kåberg - Harm Reduction Journal, 2023 - Springer
Background People who inject drugs (PWID) represent a population with an increased
prevalence of hepatitis C (HCV) infections. HCV treatment among PWID is essential to reach …